refractory to standard therapy
Showing 9976 - 10000 of >10,000
Epilepsy Trial in Worldwide (Keppra® extended release formulation - XR, Placebo)
Completed
- Epilepsy
- Keppra® extended release formulation - XR
- Placebo
-
Curitiba, Brazil
- +33 more
Jun 29, 2020
Hidradenitis Suppurativa Trial in Detroit (Cryoinsufflation, Deroofing)
Terminated
- Hidradenitis Suppurativa
- Cryoinsufflation
- Deroofing
-
Detroit, MichiganDepartment of Dermatology, Henry Ford Medical Center, 3031 West
Apr 26, 2023
Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)
Not yet recruiting
- Human Immuno-deficiency Virus (HIV) Disease
- Budigalimab
- +3 more
- (no location specified)
Sep 5, 2023
Scar, Hidradenitis Suppurativa Trial (device, procedure, drug)
Not yet recruiting
- Scar
- Hidradenitis Suppurativa
- Triamcinolone Topical
- +2 more
- (no location specified)
Oct 6, 2022
Hematologic Malignancies Trial in Hangzhou (RD13-01 cell infusion)
Completed
- Hematologic Malignancies
- RD13-01 cell infusion
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,College of Medicine, Zhejiang Univ
Jan 8, 2022
COVID-19 Pandemic Trial in Bani Suwayf (Enoxaparin, Hydroxychloroquine)
Completed
- COVID-19 Pandemic
- Enoxaparin, Hydroxychloroquine
-
Banī Suwayf, Cairo, EgyptBeni-Suef University teaching Hospital
Apr 4, 2022
Chronic Spinal Cord Injury Trial in Worldwide (LIFT System)
Recruiting
- Chronic Spinal Cord Injury
- LIFT System
-
Englewood, Colorado
- +13 more
Jul 7, 2022
HIV-HEART Aging Study (15 Year Follow up)
Active, not recruiting
- HIV Infections
- +6 more
-
Essen, Nordrhein-Westfalen, Germany
- +4 more
Jan 9, 2023
Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma Trial in France, Italy, Spain (Standard treatment: Control arm,
Not yet recruiting
- Cervical Carcinoma
- +2 more
- Standard treatment: Control arm
- Experimental arm
-
Bordeaux, France
- +18 more
Oct 12, 2022
Smoking Cessation Trial (Music intervention, Nicotine replacement)
Not yet recruiting
- Smoking Cessation
- Music intervention
- Nicotine replacement
- (no location specified)
Nov 16, 2023
Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T
Recruiting
- Hodgkin's Disease
- +3 more
- EBV-specific T cells: A
- EBV-specific T cells: B
-
Houston, Texas
- +1 more
Jun 28, 2022
Postoperative Pain, Fibroid Uterus Trial in Beachwood (Bupivacain, Saline)
Not yet recruiting
- Postoperative Pain
- Fibroid Uterus
-
Beachwood, OhioUniversity Hospitals Ahuja Medical Center
Jul 28, 2023
Anxiety, Dental Trial in Brest (Virtual reality, Standard)
Recruiting
- Anxiety, Dental
- Virtual reality
- Standard
-
Brest, Finistère, FranceCHRU de Brest
Jun 10, 2022
Osteomyelitis Trial in Louisville (oral antibiotics, intravenous antibiotics)
Terminated
- Osteomyelitis
- oral antibiotics
- intravenous antibiotics
-
Louisville, KentuckyUniversity of Louisville
Apr 2, 2021
Retina Disease, Retinopathy of Prematurity, Ranibizumab Trial in Zagazig (Ranibizumab (0.25 mg/0.025 mL))
Completed
- Retina Disease
- +2 more
- Ranibizumab (0.25 mg/0.025 mL)
-
Zagazig, EgyptZagazig University, Faculty of medicine
Jan 26, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Little Rock, Arkansas
- +144 more
Dec 3, 2021
Gastric Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Houston (Aerobic Exercise, Dietary Intervention, Nutritional
Withdrawn
- Gastric Adenocarcinoma
- Pancreatic Adenocarcinoma
- Aerobic Exercise
- +5 more
- (no location specified)
Oct 26, 2022
Metastatic Prostate Cancer Trial in New York ([F-18] DCFPyL, PET/CT imaging)
Active, not recruiting
- Metastatic Prostate Cancer
- [F-18] DCFPyL
- PET/CT imaging
-
New York, New YorkColumbia University Irving Medical Center
May 6, 2022
Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in
Active, not recruiting
- Anatomic Stage IIIB Breast Cancer AJCC v8
- +4 more
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2022
Shock, Whole Blood, and Assessment of TBI S.W.A.T. (LITES TO 2)
Active, not recruiting
- Hemorrhagic Shock
- Traumatic Brain Injury
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Feb 10, 2022
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Relapsed or Refractory Multiple Myeloma, Hematological Malignancy Trial in Maroochydore, Tugun, Frankston (SG301)
Not yet recruiting
- Relapsed or Refractory Multiple Myeloma
- Hematological Malignancy
-
Maroochydore, Queensland, Australia
- +2 more
Dec 21, 2020
Small Cell Lung Cancer Extensive Stage Trial (Pembrolizumab, Plinabulin plus Etoposide and Platinum)
Not yet recruiting
- Small Cell Lung Cancer Extensive Stage
- Pembrolizumab, Plinabulin plus Etoposide and Platinum
- (no location specified)
Feb 15, 2023
IBD Trial in Leiden (Ferrous fumarate, MonoFer)
Recruiting
- Inflammatory Bowel Diseases
- Ferrous fumarate
- MonoFer
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Centre
Oct 12, 2022